Skip to main content
Commercial newswire·IL·

Theranica's AI Achieves 91% Precision on Next-Day Migraine Likelihood in Largest Study of Its Kind

Peer-reviewed study of 53,000 Nerivio users finds a patient's own headache pattern over the past 30 days, not the prodromal symptoms clinicians have watched for decades, is the strongest warning sign of tomorrow's migraine attack BRIDGEWATER, N.J. and CAESAREA, Israel, Sept. 23, 2026...

Short extract only — this publisher licenses its text. Read the full release at the source.

More from Commercial newswire

The rest of this wire is for subscribers

Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.

7 days, no card required.

Read releases like this the second they cross the wire.

1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.

Start the free trial →

Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.

PPN Source →
Shared via PPN World — real-time press release intelligence.